Efficacy of ursodeoxycholic acid treatment and endoscopic dilation of major duct stenoses in primary sclerosing cholangitis. An 8-year prospective study

Journal of Hepatology

Volumn 26, Issue 3, 1997, Pages 560-566

  Stiehl, Adolf ^a   Rudolph, Gerda ^a   Sauer, Peter ^a   Benz, Christine ^a   Stremmel, Wolfgang ^a   Walker, Siegfried ^a   Theilmann, Lorenz ^a  

^a NONE

Author keywords

biliary disease; cholestasis; endoscopic intervention; liver disease; ursodeoxycholic acid

Indexed keywords

BILIRUBIN; PLACEBO; URSODEOXYCHOLIC ACID;

ADOLESCENT; ADULT; AGED; ARTICLE; BALLOON DILATATION; BILE DUCT OBSTRUCTION; BILE DUCT STONE; CONTROLLED STUDY; DRUG EFFICACY; ENDOSCOPY; FEMALE; HISTOLOGY; HUMAN; LIVER BIOPSY; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCLEROSING CHOLANGITIS; SURVIVAL;

EID: 0031052006     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(97)80421-7     Document Type: Article

References (39)

1. Chapman RW, Arborgh BA, Rhodes JM, Summerfield JA, Dick R, Scheuer PJ, Sherlock S. Primary sclerosing cholangitis - a review of its clinical features, cholangiography and hepatic histology. Gut. 21:1980;870-877.
2. Wiesner RH, LaRusso NF. Clinicopathologic features of the syndrome of primary sclerosing cholangitis. Gastroenterology. 79:1980;200-206.
3. Helzberg JH, Petersen JM, Boyer JL. Improved survival with primary sclerosing cholangitis. A review of clinicopathologic features and comparison of symptomatic and asymptomatic patients. Gastroenterology. 92:1987;1869-1875.
4. Lindor KD, Wiesner RH, MacCarthy RL, Ludwig J, LaRusso NF. Advances in primary sclerosing cholangitis. Am J Med. 89:1990;73-80.
5. Farrant MJ, Hayllar KM, Wilkinson ML, Karani J, Portmann BC, Westaby D, Williams R. Natural history and prognostic variables in primary sclerosing cholangitis. Gastroenterology. 100:1991;1710-1717.
6. Lee Y-M, Kaplan MM. Primary sclerosing cholangitis. N Engl J Med. 332:1995;924-933.
7. Ismail T, Angrisani L, Lowell JE, Hübscher S, Buckels J, Neuberger J, Elias E, McMaster P. Primary sclerosing cholangitis: surgical options, prognostic variables and outcome. Br J Surg. 78:1991;564-567.
8. Wiesner RH, Porayko MK, Dickson ER, Gores GJ, LaRusso N, Hay JE, Wahlstrom HE, Krom RAF. Selection and timing of liver transplantation in primary biliary cirrhosis and primary sclerosing cholangitis. Hepatology. 16:1992;1290-1299.
9. Strasse S, Sheil AGR, Gallagher ND, Waugh R, McCaughan GW. Liver transplantation for primary sclerosing cholangitis versus primary biliary cirrhosis: A comparison of complications and outcome. J Gastroenterol Hepatol. 8:1993;238-243.
10. Narumi S, Roberts JP, Emond JC, Lake J, Ascher NL. Liver transplantation for sclerosing cholangitis. Hepatology. 22:1995;451-457.
11. Poupon R, Poupon RE, Calmus Y, Chretien Y, Ballet F, Darnis F. Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis? Lancet. i:1987;834-836.
12. Leuschner U, Fischer H, Kurtz W, Guldutuna S, Hubner K, Hellstern A, Gatzen M, Leuschner M. Ursodeoxycholic acid in primary biliary cirrhosis: results of a controlled doubleblind trial. Gastroenterology. 97:1989;1268-1274.
13. Poupon RE, Balkau B, Eschwege E, Poupon R. A multicenter controlled trial of ursodiol for the treatment of primary biliary cirrhosis. N Engl J Med. 324:1991;1548-1554.
14. Combes B, Carithers RL, Maddrey WC, Lin D, McDonald MF, Wheeler DE, Eigenbrodt EH, et al. A randomized, double-blind, placebo-controlled trial of ursodeoxycholic acid in primary biliary cirrhosis. Hepatology. 22:1995;759-766.
15. Lindor KDL, Dickson ER, Baldus WP, Jorgensen RA, Ludwig J, Murtaugh PA, Harrison JM, Wiesner RH, Anderson ML, Lange SM, Lesage G, Rossi SS, Hofmann AF. Ursodeoxycholic acid in the treatment of primary biliary cirrhosis. Gastroenterology. 106:1994;1284-1290.
16. Heathcote EJL, Cauch-Dudek K, Walker V, Bailey RJ, Blendis LM, Ghent CN, Micheiletti P, Minuk GY, Papas SC, Scully LJ, Steinbrecher UP, Sutherland LR, Williams CN, Witt-Sullivan H, Worobetz LJ, Milner RA, Wanless IR. The Canadian multi-center double blind randomized controlled trial of ursodeoxycholic acid in primary biliary cirrhosis. Hepatology. 19:1994;1149-1156.
17. Stiehl A, Raedsch R, Kommerell B. The effect of ursodeoxycholate in primary sclerosing cholangitis. A comparison to primary biliary cirrhosis. Abstract Gastroenterology. 94:1988;595.
18. Hayashi H, Hihucchi T, Ichimiya H, Hishida N, Sakamoto N. Symptomatic primary sclerosing cholangitis treated with ursodeoxycholic acid. Gastroenterology. 99:1990;533-535.
19. Chazouilleres O, Poupon R, Capron J-P, Metman E-H, Dhumeaux D, Amouretti M, Couzigou P, Labayle D, Trinchet J-C. Ursodeoxycholic acid for primary sclerosing cholangitis. J Hepatol. 11:1990;120-123.
20. O'Brien CB, Senior JR, Arora-Mirchandi R, Batta A, Salen G. Ursodeoxycholic acid for the treatment of primary sclerosing cholangitis: a 30 months pilot study. Hepatology. 14:1991;838-847.
21. Lebovics E, Salama M, Elhosseiny A, Rosenthal WS. Resolution of radiograhic abnormalities with ursodeoxycholic acid therapy of primary sclerosing cholangitis. Gastroenterology. 102:1992;2143-2147.
22. Beuers U, Spengler U, Kruis W, Aydemir Ü, Wiebecke B, Heldwein W, Weinzierl M, Pape GR, Sauerbruch T, Paumgartner G. Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: a placebo controlled trial. Hepatology. 16:1992;707-714.
23. Stiehl A, Walker S, Stiehl L, Rudolph G, Hofmann WJ, Theilmann L. Effects of ursodeoxycholic acid on liver and bile duct disease in primary sclerosing cholangitis. A 3 year pilot study with a place-controlled study period. J Hepatol. 20:1994;57-64.
24. Dickson ER, Murtaugh PA, Wiesner RH, Grambsch PM, Fleming TR, Ludwig J, LaRusso NF, Malinchoc M, Chapman RW, Kaplan MM, Maddrey WC, Williams R, Farrant M, Langworthy A. Primary sclerosing cholangitis: Refinement and validation of survival models. Gastroenterology. 103:1992;1893-1901.
25. Abu-Elmagd KM, Malinchoc M, Dickson ER, Fung JJ, Murtaugh PA, Langworthy AL, Demetris AJ, Krom RAF, Van Thiel DH, Strazl TE. Efficacy of hepatic transplantation in patients with primary sclerosing cholangitis. Surg Gynecol Obstet. 177:1993;335-344.
26. Ludwig J, Barham SS, LaRusso NF, Elveback LR, Wiesner RH, McCall JT. Morphologic features and chronic hepatitis associated with primary sclerosing cholangitis and chronic ulcerative colitis. Hepatology. 1:1981;632-640.
27. Woolson RF. Rank tests and a one-sample log rank test for comparing observed survival data to a standard population. Biometrics. 37:1981;687-696.
28. Harrington DP, Fleming TR. A class of rank test procedures for censored survival data. Biometrika. 69:1982;553-566.
29. Stiehl A. Ursodeoxycholic acid therapy in treatment of primary sclerosing cholangitis. Scand J Gastroent. 29:1994;59-61. (Suppl 209).
30. Grijm R, Huibregtse K, Bartelsman J, Mathus-Vliegen EMH, Dekker W, Tytgat GNJ. Therapeutic investigations in primary sclerosing cholangitis. Dig Dis Sci. 31:1986;792-798.
31. Johnson GK, Geenen JE, Venu RP, Hogan WJ. Endoscopic treatment of biliary duct strictures in sclerosing cholangitis; Follow up assessment of a new therapeutic approach. Gastrointest Endosc. 33:1987;9-12.
32. Huitbregtse K. Therapeutic investigations in primary sclerosing cholangitis. Huitbregtse K. Endoscopic Biliary and Pancreatic Drainge. 78-85:1988;Georg Thieme, Stuttgart.
33. Cotton PB, Nickl N. Endoscopic and radiologic approaches to therapy in primary sclerosing cholangitis. Semin Liver Dis. 11:1991;40-48.
34. Craig PI, Hatfield RW. Endoscopic therapy in primary sclerosing cholangitis. Eur J Gastroenterol Hepatol. 4:1992;284-287.
35. Gaing AA, Geders JM, Cohen SA, Siegel JH. Endoscopic management of primary sclerosing cholangitis review, and report of an open series. Am J Gastroenterol. 88:1993;2000-2008.
36. Lee JG, Schutz SM, England RE, Leung JW, Cotton PB. Endoscopic therapy of sclerosing cholangitis. Hepatology. 21:1995;661-667.
37. Poupon RE, Poupon R, Balkau B. Ursodiol for long-term therapy of primary biliary cirrhosis. N Engl J Med. 330:1994;1342-1347.
38. Simko V, Michael S, Prego V. Ursodeoxycholic therapy in chronic liver: A meta analysis in primary biliary cirrhosis and in chronic hepatitis. Am J Gastroenterol. 89:1994;392-398.
39. Heathcote EJ, Lindor KD, Poupon R, Cauch-Dudek K, Dickson ER, Trout R, Poupon RE. Combined analysis of French, American and Canadian randomized controlled trial of ursodeoxycholic acid therapy in primary biliary cirrhosis. Abstract Gastroenterology. 108:1995;A1082.